课题基金 / 基金详情

MAO/F CLONING AND PRODUCTION OF HIV-1 ENVELOPE PROTEINS

MAO/F CLONING AND PRODUCTION OF HIV-1 ENVELOPE PROTEINS
HIV-1 包膜蛋白的 MAO/F 克隆和生产
批准号:
2662808
负责人:
WILLIAM C OLSON
金额:
$73.86万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 1999-09-29

项目摘要

项目成果

WILLIAM C OLSON的其他基金

相似基金

相关文献

中文摘要
翻译
HIV包膜蛋白被认为是艾滋病的一个重要靶标
英文摘要
The envelope protein of HIV is considered an integral target of AIDS vaccine design. Since this proteins is present on virus particles and infected cells, it is reasonable to predict that immunity raised to env will be a quintessential part of any vaccine, if not essential. A problem with this however, is that different HIV clades have different envelope proteins that can be recognized as different to the immune system. Also, the envelops can exist in different structural forms. The objectives of this contract will be to clone various specific envelope genes of HIV and engineer expression vectors capable of expressing the given envelope proteins in vitro. Next, these envelope proteins will be purified so as to permit their administration to experimental animals to test their immunogenicity. Different forms, monomeric and oligomeric, will be generated and purified. The particular env genes will be identified by the Project Officer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
  • 批准号:
    8278036
  • 项目类别:
  • 资助金额:
    $14.25万
  • 财政年份:
    2011
  • 负责人:
    WILLIAM C OLSON
  • 依托单位:
PA-50/PA-41 antitoxin antibody therapy for C. difficile infection
  • 批准号:
    8261683
  • 项目类别:
  • 资助金额:
    $112.85万
  • 财政年份:
    2011
  • 负责人:
    WILLIAM C OLSON
  • 依托单位:
PA-50/PA-41 antitoxin antibody therapy for C. difficile infection
  • 批准号:
    8110233
  • 项目类别:
  • 资助金额:
    $112.37万
  • 财政年份:
    2011
  • 负责人:
    WILLIAM C OLSON
  • 依托单位:
Trimer Production and Immunogenicity Testing
  • 批准号:
    7661038
  • 项目类别:
  • 资助金额:
    $97.59万
  • 财政年份:
    2009
  • 负责人:
    WILLIAM C OLSON
  • 依托单位:
海外基金